Thomas Engleitner
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 16
- Immune Cell Function and Interaction 6
- Immune cells in cancer 4
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 4
- Co-authors
- Roland Rad (34 shared papers)Julia Weber (3 shared papers)Angela M. Krackhardt (1 shared paper)Julia Slotta‐Huspenina (1 shared paper)Rüdiger Hein (1 shared paper)Michal Bassani‐Sternberg (1 shared paper)Katja Specht (1 shared paper)Marc E. Martignoni (1 shared paper)
- Journals
- Nature Communications (7 papers)Malaria Journal (3 papers)Scientific Reports (2 papers)Blood (2 papers)The EMBO Journal (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Thomas Engleitner
41 papers receiving 1.4k citations
Thomas Engleitner's Hit Papers
Peers
Comparison fields: 5 of 84
- Immunology 654
- Oncology 372
- Cancer Research 138
- Parasitology 64
- Molecular Biology 653
Countries citing papers authored by Thomas Engleitner
This map shows the geographic impact of Thomas Engleitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Engleitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Engleitner more than expected).
Fields of papers citing papers by Thomas Engleitner
This network shows the impact of papers produced by Thomas Engleitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Engleitner. The network helps show where Thomas Engleitner may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Engleitner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry Hit paper breakdown → | 2016 | 478 |
| 2 | 2019 | 97 | |
| 3 | 2018 | 82 | |
| 4 | 2019 | 60 | |
| 5 | 2021 | 54 | |
| 6 | 2017 | 49 | |
| 7 | 2014 | 48 | |
| 8 | 2023 | 42 | |
| 9 | 2021 | 31 | |
| 10 | 2019 | 30 | |
| 11 | 2017 | 27 | |
| 12 | 2021 | 26 | |
| 13 | 2019 | 25 | |
| 14 | 2020 | 24 | |
| 15 | 2013 | 24 | |
| 16 | 2015 | 24 | |
| 17 | 2014 | 23 | |
| 18 | 2024 | 21 | |
| 19 | 2021 | 21 | |
| 20 | 2018 | 19 |
About Thomas Engleitner
Thomas Engleitner is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 41 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), Immune cells in cancer (4 papers), Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (4 papers), Cancer Genomics and Diagnostics (3 papers), Malaria Research and Control (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Immunology (654 citations), Oncology (372 citations), Cancer Research (138 citations), Parasitology (64 citations) and Molecular Biology (653 citations). Thomas Engleitner has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Roland Rad, Julia Weber, Angela M. Krackhardt, Julia Slotta‐Huspenina, Rüdiger Hein, Michal Bassani‐Sternberg, Katja Specht, Marc E. Martignoni, Dirk H. Busch and Pavel Sinitcyn. Their work appears in journals such as Nature Communications, Malaria Journal, Scientific Reports, Blood and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.